DOCSLIB.ORG

NEX China 2019 June 18-20, 2019 · SNIEC, Shanghai, China Exhibitors & Products

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NEX China 2019 June 18-20, 2019 · SNIEC, Shanghai, China Exhibitors & Products NEX China 2019 June 18-20, 2019 · SNIEC, Shanghai, China Exhibitors & Products Booth Company Name Products E5B98# ACE Biotechnology Co., Ltd. ginkgo biloba extract,Flaxseed Lignans, Pomegranate PE,Echinacea PE,St.John's wort PE,Eleuther PE,Black Cohosh E4P27 Acetar Bio-Tech Inc. PE,Horse Chestnut PE,Onion PE,Tribulus Terrestris PE,Epimedium PE E5G38 AEVER CO.,LTD Natural ferulic acid ,Oryzanol,Rice bran wax,Methyl oleate NFlav® Organic Chinese Cinnamon Extract Powder, Polygonum Aviculare Extract Powder, Radix Gentianae Extract Powder, Herba E5C38 AG ORGANIC INC/JORYHERB LTD Verbenae Extract Powder, Herba Rumicis Extract Powder, Flores Sambuci Extract Powder E5C86 Aktin Chemicals, Inc. E5E62 AlgaNovo International Co., Ltd. Fucoidan（9072-19-9 ）,fucoxanthin(3351-86-8） ALPS PHARMACEUTICAL IND. E4F90 CO.,LTD E4A60 Aminodiscovery Co., Ltd. E4C38 Angel Yeast Co.,Ltd. Selenium Yeast，Chromium Yeast，Yeast Beata Glucan E5A58 ANHUI CAPA BIO-TECH CO.,LTD. garlic oil,ginger oil Cholesterol,Pig Bile Powder,Ox Bile Powder,Cholic Anhui Chem-Bright Bioengineering E5A35 Acid,Bilirubin,Sodium Cholate,Deoxycholic Acid,Sodium Co.,Ltd. Deoxycholate,Hyodeoxycholic Acid,Chenodeoxycholic Acid L-Arabinose,D-（+）-Galactose, L-Rhamnose monohydrate , D- ANHUI HEGENG BIOTECH Glucuronic acid,Uridine diphosphate glucuronic acid （UDP- E5E40 ENGINEERING CO.,LTD GlcA,Uridine diphosphate glucose (UDP-Glucose) , D-Glucaric acid （Saccharic acid） Anhui Redstar Pharmaceutical Corp., E4F66 tea polyphenol、natural caffeine、instant tea Ltd Ginkgo Biloba.Ginseng extract.Silymarin.Yohimbe.Skullcap.Grape skin.Salvia Miltiorrhiza P.E. Carthamin yellow. jianghuang extract. Cranberry extract. Grape seed. Mulberry teaf. Honeysuckle extract. ANHUI TIANYANG Pomegranate. Garlic powder&Granule. Artemisia argyi. Wolfberry. E5A60 PHARMACEUTICAL CO.,LTD. Ginger extract. Dandelion extract. Tribulus terrestris extract. Rhodiola extract. Epimedium extract. St john\'s wort extract. Stevia extract. Fruit juice concentrate. Green coffee bean extract. Pure natural lycopene ANHUI XINZHOU MARINE E5Q28 EPA, DHA, OMEGA-3 fatty acid, Deep sea fish oil BIOLOGICAL PRODUCTS CO., LTD. bacavir Sulfate（CAS No.188062-50-2）,N-(2-Amino-4，6-dichloro- 5-pyrimidinyl)formamide（CAS No.171887-03-9）,Afatinib (CAS No.850140-72-6),N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4- quinazolinamine (CAS No.162012-67-1),7-Fluoro-6-nitro-4- E4A59 Arcadia Biotechnology Ltd hydroxyquinazoline(CAS No.162012-69-3),N4-(3-Chloro-4- fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4，6- quinazolinediamine(CAS No.314771-76-1),(S)-(+)-3- Hydroxytetrahydrofuran (CAS No.86087-23-2),Agomelatine(CAS No.138112-76-2) E5B35 Auqi Marine Bio-tech Co.,Ltd Acetyl Hexapeptide-3 (Argireline),Pentapeptide-3 (Leuphasyl),Heptapeptide (Snap 7),Acetyl Octapeptide-3 (Snap 8),Dipeptide Diaminobutyroyl Benzylamide (Syn Ake),Pentapeptide- 3 (Vialox),Palmitoyl Pentapeptide-3 (Matrixyl),Hexapeptide-10 E4A59 Aviva Pharmaceuticals Ltd. (Serilesine),Palmitoyl Oligopeptide,Carnosine,Copper Peptide (Aldeline),Acetyl Tetrapeptide-5,Palmitoyl Tetrapeptide - 3,Nonapeptide,Glutathione,Benzeneacetaldehyde (CAS No.93-53- 8),beta-Methylphenethyl Alcohol (CAS No.1123-85-9) Grape seed extract; 5-HTP; olive leaf extract; L-Theanine; L- E5C66 BannerBio Nutraceuticals inc Glutathione reduced BAODING FAITHFUL INDUSTRY Sodium hyaluronate, pancreatin, pepsin, olive leaf extract, E5D58 CO.,LTD. pomegranate extract,Pullulan Acai Berry Extract, Almond Extract Amygdalin, Aloe Extract, Amur Corktree Bark Extract, Acerola Cherry Extract Powder, Chokeberry E5G41 Baoji Oasier Bio-tech Co., Ltd P.E Aronia Extract Chokeberry 15% Anthocyanidin, Cranberry Extract Baosan Zeyuan Alage Health E5F31 Technology Co.,Ltd Beijing Gingko-Group Biological AstaZine™ Astaxanthin / ApplePhenon® Polyphenols / ThinOgen™ E4C20 Technology Co., Ltd. Fucoxanthin / Ginnovay™ Tocotrienols / Licorice extract E5E68 Bengbu Huadong Bio-tech Co., Ltd stevia Stevia ，stevia blends，gardenia yellow pigment, lotus flavones and E4G35 Biolotus Technology Lasa Inc. so on Bontac Bio-engineering (Shenzhen) E4D26 NMN, NAD(H), Apigenin, phosphatidylserine, L-glutathione Co., Ltd. Sunflower Lecithin Liquid(Oil Soluble) Sunflower Lecithin Liquid(Water Soluble) Sunflower Lecithin Powder/Granuels NON- Boshuai Biotechnology (Tianjin) Co., E5F40 GMO Soya Lecithin Soya Lecithin Liquid(Oil Soluble) Soya Lecithin Ltd Liquid(Water Soluble) Soya Lecithin Powder/Granuels Glycerol Phosphate Acid Choline Phosphatidylserine Phosphatidyl choline isoquercitin,prunin,taxifolin,bacopaside Catch Bio-science & technology Co., E4G86 I,phloridzin,phloretin,Theaflavins,Catechins,astilbin,naringenin,triloba Ltd tin,hesperetin-7-O-β-D -glucoside Changge Shengyuan Bee Industry E5G15 Co.,Ltd Resveratrol, Amygdalin 98%, Red clcover extract, Tongkat ali extract, Echinacea Extract, 100% Natural Rhodiola Rosea Extract E5A69 Changsha Heking Bio-tech Co., Ltd 3% Rosavins 5% Salidroside, Natural sweetener Luo han guo extract Changsha Huir Biological-Tech Co., Milk Thistle Extract/ Hesperidin/ Resveratrol/ L-Glutathione E5Q06 Ltd. Reduced/ Stevia Chlorogenic acid (5-98%), Amygdalin (98%), Laetrile (98%),Ursolic acid (25-98%), Corosolic Acid (1-98%), Icariin (10-98%), Dihydromyricetin (98%), Maslinic acid（1-20%), Emodin (50- 98%),Magnolol(50-98%), Magnolia bark extract (50-98%),Honokiol Changsha Staherb Natural Ingredients E5E98 (50-98%), Myricetin (50-90%),Banaba leaf P.E(1-98%),Aloe Co., Ltd. emodin(50-98%),Aloin(10- 98%),Rhein(98%),Paeoniflorin(10%),Chamomile extract - apigenin(0.3-98%),Luteolin(98%),Macleaya cordata extract(20- 60%),Fisetin(50-98%) Changsha Zhongren Biotechnology Huperzine A ,Paeoniflorin , Phlorizin ,Chlorogenic acid,,Tongkat Ali E5C42b Co.,Ltd. extract,Maca extract ,Huperzia Serrate Extract E4A67 Chengdu CSHPHARM Co.,Ltd. Chengdu Hawk Bio-Engineering Hesperidin, Diosmin, Hesperidin+Diosmin9:1, Citrus Bioflavonoids, E4A90 Co.,Ltd. Synephrine Chengdu Junyikang biological RUTIN,TROXERUTIN,QUERCETIN,L-RHAMNOSE,BERBERINE E5G32 technology Co.,Ltd HYDROCHLORIDE Cycloastragenol 98%, Astragaloside IV 98%, Astragalus Chengdu King-tiger Bio. Tech. Co., E4E67 Polysaccharides, Galangin 98%, Genipin 98%, Cycloastragenol Ltd. 90%, Cycloastragenol 50%, Cycloastragenol 10% 1、Diosmin EP8.3, Diosmin micronization, Diosmin Granulated; 2、 Chengdu Okay Pharmaceutical E5D02 Rutin NF11, Rutin EP8.0, Rutin DAB10; 3、Quercetin; 4、Berberine CO.,LTD hydrochloride; 5、Citrus Bioflavonoids Chengdu Runde Pharmaceutical Co., Diosmin, Hesperidin Methyl Chalcone.,Methyl E4A51 Ltd. Hesperidine,Diosmetin,Hesperetin,Naringenin Chengdu Shuxi Pharmaceutical E4F02 Co.,Ltd./ Chengdu Pujiang Shuxi Plant Hesperidin, Diosmin, Synephrine, Narigin, Neohesperidin etc. Biochemical Co.,Ltd Green Tea Polyphenols, L-Theanine, Tea Theaflavins, EGCG, E4F08 Chengdu Wagott Bio-tech Co., Ltd Resveratrol Chengdu Yazhong Bio-pharmaceutical E5A12 Diosmin, Diomsin/Hesperidin Co., Ltd. Lutein、Lycopene、Grape Seed Extract、Green Coffee Bean E5P08 Chenguang Biotech Group Co.,Ltd. Extract、Stevioside Chongqing Joywin Natural Products E5P02 POLYGONUM CUSPIDATUM P.E., PREBIOTICS SERIES Co. Ltd. Silymarin, Silibin, Salvianic Acid A, , Tanshinone IIA, Salvianic Acid E4G68 Da Li Hou De Biotech Ltd B)and White Peony Extract (Paeoniflorin), Ginger Root Extract,White Peony Extract DALIAN TIANSHAN INDUSTRIAL E4E62 CO., LTD. 1.Blueberry Anthocyanin 2.Grape Seed Extract；3.GSE Pine Bark Extract4.Silymarin、Silymarine , Milk Thistle Extract, Milk Thistle P.E.5.Lingonberry Anthocyanin6.Blackcurrent DaXingAnLing Lingonberry Boreal Anthocyanin7.Cowberry Red8. Elderberry Anthocyanin9.Black Rice E5D31 Biotech Co.,Ltd Anthocyanin10.Honeysuckle Extract(Lonicera caerulea Anthocyanin, Sweetberry Anthocyanin, Blue-berried Honeysuckle Anthocyanin)11.Red Raspberry Anthocyanin12.Cranberry Anthocyanin13.Cranberry Extract powder E5A79 Derun Silymarin Co.,Ltd. Milk Thistle Extract,Silymarin,Silymarin soluble,Silybin E4D56 Dongcheng Biotech Co.,Ltd. Polygonum cuspidatum extract (Resveratrol) 、Soybean extract DONGMING GROWTH E4C30 (Soy isoflavone ) 、Phellodendron bark extract(Berberine BIOTECHNOLOGY CO.,LTD hydrochloride) 、Gingko biloba leaf extract Dongming Huiren Biological products E5E33 Soy isoflavones Co.,Ltd. Dongming Shengyuan Biochemical E5B27 Soybean isoflavones in private enterprises.Soybean Isoflavone Technology Co., Ltd. E5G65 Elionnature Biotechnology FUJIAN HIGH FORTUNE BIO-TECH Fish oil raw material of Food Grade,Fish oil raw material of Health E5D42 CORP. Grade Fuqing King Dnarmsa Spirulina Co., E5B63 Chlorella,Phycocyanin,Dunaliella salina Ltd. Rosemary Extract,Mulberry Leaf Extract,Fenugreek Seed E5A66 Geneham Pharmaceutical Co.,Ltd Extract,Tea Saponin E4F56 Golden Health Technology Co.,Ltd. Collagen Type II Powder、Collagen Type II Granule、Fish Collagen Powder、Fish Collagen Granule、Bovine Collagen Powder、Bovine E5C12 Gongan Lijing Biochemical Co.,Ltd. Collagen Granule 、Chondroitin Sulfate、MSM、Glucosamine、 Hyaluronic Acid. Ganoderma Lucidum Extract,Cordyceps Extract,Maitake E5G08b Goodex Mushroom Biotech Co., Ltd Extract,Macha powder Guang'an Hongyi Bio-Technology Co., E5D33 Resveratrol,Berberine Chloride,Salvia Extract,Baicalin Extract Ltd. GUANGDONG KUAN-LUNG E5B62 BIOTECHNOLOGY CO.,LTD. American ginseng Extract、Asia GinsengExtract、Asian Ginseng Guangdong Qinyunshan E5C02 Stem and LeafExtract、Panax NotoginsengExtract、Reishi Pharmaceutical Co., Ltd Mushroom Extract Guangxi Chanfang Pharmaceutical E5A81 Plant extracts,Rutin Co.,Ltd. Our ability of Artemisinin production reaches more than 50 tons Guangxi xiancaotang
Load more

Recommended publications
  • (12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski Et Al
    USOO9421 180B2 (12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski et al. (45) Date of Patent: Aug. 23, 2016 (54) ANTIOXIDANT COMPOSITIONS FOR 6,203,817 B1 3/2001 Cormier et al. .............. 424/464 TREATMENT OF INFLAMMATION OR 6,323,232 B1 1 1/2001 Keet al. ............ ... 514,408 6,521,668 B2 2/2003 Anderson et al. ..... 514f679 OXIDATIVE DAMAGE 6,572,882 B1 6/2003 Vercauteren et al. ........ 424/451 6,805,873 B2 10/2004 Gaudout et al. ....... ... 424/401 (71) Applicant: Perio Sciences, LLC, Dallas, TX (US) 7,041,322 B2 5/2006 Gaudout et al. .............. 424/765 7,179,841 B2 2/2007 Zielinski et al. .. ... 514,474 (72) Inventors: Jan Zielinski, Vista, CA (US); Thomas 2003/0069302 A1 4/2003 Zielinski ........ ... 514,452 Russell Moon, Dallas, TX (US); 2004/0037860 A1 2/2004 Maillon ...... ... 424/401 Edward P. Allen, Dallas, TX (US) 2004/0091589 A1 5, 2004 Roy et al. ... 426,265 s s 2004/0224004 A1 1 1/2004 Zielinski ..... ... 424/442 2005/0032882 A1 2/2005 Chen ............................. 514,456 (73) Assignee: Perio Sciences, LLC, Dallas, TX (US) 2005, 0137205 A1 6, 2005 Van Breen ..... 514,252.12 2005. O154054 A1 7/2005 Zielinski et al. ............. 514,474 (*) Notice: Subject to any disclaimer, the term of this 2005/0271692 Al 12/2005 Gervasio-Nugent patent is extended or adjusted under 35 et al. ............................. 424/401 2006/0173065 A1 8/2006 BeZwada ...................... 514,419 U.S.C. 154(b) by 19 days. 2006/O193790 A1 8/2006 Doyle et al.
    [Show full text]
  • 2013 Book Antioxidantpropertie
    Antioxidant Properties of Spices, Herbs and Other Sources Denys J. Charles Antioxidant Properties of Spices, Herbs and Other Sources Denys J. Charles Frontier Natural Products Co-op Norway, IA , USA ISBN 978-1-4614-4309-4 ISBN 978-1-4614-4310-0 (eBook) DOI 10.1007/978-1-4614-4310-0 Springer New York Heidelberg Dordrecht London Library of Congress Control Number: 2012946741 © Springer Science+Business Media New York 2013 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, speci fi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on micro fi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied speci fi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a speci fi c statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
    [Show full text]
  • Will the Traditional Medicine Un-Pause the World and Decide the Fate of Covid-19?
    International Journal of Applied Pharmaceutics ISSN- 0975-7058 Vol 13, Issue 2, 2021 Review Article WILL THE TRADITIONAL MEDICINE UN-PAUSE THE WORLD AND DECIDE THE FATE OF COVID-19? JANANI S. K.1, DHANABAL S. P.2, SURESHKUMAR R.3*, CHENMALA KARTHIKA4, SAI SURYA NIKITHA UPADHYAYULA5 1,3*,4,5Department of Pharmaceutics, 2Department of Pharmacognosy and Phytopharmacy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty 643001, The Nilgiris, Tamil Nadu, India Email: [email protected] Received: 30 Nov 2020, Revised and Accepted: 12 Jan 2021 ABSTRACT COVID-19 is a life-threatening disease that mainly affects the human respiratory system. In today’s world, scientists are working conscientiously for the identification of promising drugs and vaccines. But, when we look back to the former times, herbal medicines were considered for curing most of the diseases; luckily, nowadays, natural remedies are being carried forward by few researchers even for the treatment of most life-threatening diseases like cancer, diabetes and alzheimer’s etc. So, why can't we attempt the herbal formulation for the management of COVID-19 too? Since there is no proper scientific validation for traditional herbs and spices; it just can’t be simply ignored. When a product with less or few side effects can be prepared and made available for the benefit of people, there is nothing wrong in pondering them. Thus, keeping these points in mind, in this article, we have discussed about SARS CoV-2, their treatment options and the impact of natural remedies on both the former as well as novel coronavirus.
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • Biosynthesis of Food Constituents: Natural Pigments. Part 2 – a Review
    Czech J. Food Sci. Vol. 26, No. 2: 73–98 Biosynthesis of Food Constituents: Natural Pigments. Part 2 – a Review Jan VELÍšEK, Jiří DAVÍDEK and Karel CEJPEK Department of Food Chemistry and Analysis, Faculty of Food and Biochemical Technology, Institute of Chemical Technology in Prague, Prague, Czech Republic Abstract Velíšek J., Davídek J., Cejpek K. (2008): Biosynthesis of food constituents: Natural pigments. Part 2 – a review. Czech J. Food Sci., 26: 73–98. This review article is a part of the survey of the generally accepted biosynthetic pathways that lead to the most impor- tant natural pigments in organisms closely related to foods and feeds. The biosynthetic pathways leading to xanthones, flavonoids, carotenoids, and some minor pigments are described including the enzymes involved and reaction schemes with detailed mechanisms. Keywords: biosynthesis; xanthones; flavonoids; isoflavonoids; neoflavonoids; flavonols; (epi)catechins; flavandiols; leu- coanthocyanidins; flavanones; dihydroflavones; flavanonoles; dihydroflavonols; flavones; flavonols; anthocya- nidins; anthocyanins; chalcones; dihydrochalcones; quinochalcones; aurones; isochromenes; curcuminoids; carotenoids; carotenes; xanthophylls; apocarotenoids; iridoids The biosynthetic pathways leading to the tetrapyr- restricted in occurrence to only a few families of role pigments (hemes and chlorophylls), melanins higher plants and some fungi and lichens. The (eumelanins, pheomelanins, and allomelanins), majority of xanthones has been found in basi- betalains (betacyanins and betaxanthins), and cally four families of higher plants, the Clusiaceae quinones (benzoquinones, naphthoquinones, and (syn. Guttiferae), Gentianaceae, Moraceae, and anthraquinones) were described in the first part of Polygalaceae (Peres et al. 2000). Xanthones can this review (Velíšek & Cejpek 2007b). This part be classified based on their oxygenation, prenyla- deals with the biosynthesis of other prominent tion and glucosylation pattern.
    [Show full text]
  • The Pharmacological Potential of Rutin
    Saudi Pharmaceutical Journal (2017) 25, 149–164 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com REVIEW The Pharmacological Potential of Rutin Aditya Ganeshpurkar a,b,*, Ajay K. Saluja a,c a Faculty of Pharmacy, Gujarat Technological University, Ahmedabad, Gujarat, India b Shri Ram Institute of Technology-Pharmacy, Jabalpur, Madhya Pradesh, India c A.R. College of Pharmacy, Vallabh Vidyanagar, Gujarat, India Received 26 March 2016; accepted 24 April 2016 Available online 30 April 2016 KEYWORDS Abstract The contemporary scientific community has presently recognized flavonoids to be a Anticancer; unique class of therapeutic molecules due to their diverse therapeutic properties. Of these, rutin, Antidiabetic; also known as vitamin P or rutoside, has been explored for a number of pharmacological effects. Antimicrobial; Tea leaves, apples, and many more possess rutin as one of the active constituents. Today, rutin Organ protection; has been observed for its nutraceutical effect. The present review highlights current information Rutin and health-promoting effects of rutin. Along with this, safety pharmacology issues and SAR of the same have also been discussed. Ó 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Contents 1. Introduction . 151 2. Pharmacological actions. 151 2.1. Central nervous system . 151 2.1.1. Prevention of neuroinflammation. 151 2.1.2. Promotion of neural crest cell survival . 152 2.1.3. Sedative activity . 152 2.1.4. Anticonvulsant activity . 152 2.1.5.
    [Show full text]
  • Ep 3138585 A1
    (19) TZZ¥_¥_T (11) EP 3 138 585 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.03.2017 Bulletin 2017/10 A61L 27/20 (2006.01) A61L 27/54 (2006.01) A61L 27/52 (2006.01) (21) Application number: 16191450.2 (22) Date of filing: 13.01.2011 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • Gousse, Cecile GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO 74230 Dingy Saint Clair (FR) PL PT RO RS SE SI SK SM TR • Lebreton, Pierre Designated Extension States: 74000 Annecy (FR) BA ME •Prost,Nicloas 69440 Mornant (FR) (30) Priority: 13.01.2010 US 687048 26.02.2010 US 714377 (74) Representative: Hoffmann Eitle 30.11.2010 US 956542 Patent- und Rechtsanwälte PartmbB Arabellastraße 30 (62) Document number(s) of the earlier application(s) in 81925 München (DE) accordance with Art. 76 EPC: 15178823.9 / 2 959 923 Remarks: 11709184.3 / 2 523 701 This application was filed on 29-09-2016 as a divisional application to the application mentioned (71) Applicant: Allergan Industrie, SAS under INID code 62. 74370 Pringy (FR) (54) STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES (57) The present specification generally relates to hydrogel compositions and methods of treating a soft tissue condition using such hydrogel compositions. EP 3 138 585 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 138 585 A1 Description CROSS REFERENCE 5 [0001] This patent application is a continuation-in-part of U.S.
    [Show full text]
  • Alphabetical Listing of ATC Drugs & Codes
    Alphabetical Listing of ATC drugs & codes. Introduction This file is an alphabetical listing of ATC codes as supplied to us in November 1999. It is supplied free as a service to those who care about good medicine use by mSupply support. To get an overview of the ATC system, use the “ATC categories.pdf” document also alvailable from www.msupply.org.nz Thanks to the WHO collaborating centre for Drug Statistics & Methodology, Norway, for supplying the raw data. I have intentionally supplied these files as PDFs so that they are not quite so easily manipulated and redistributed. I am told there is no copyright on the files, but it still seems polite to ask before using other people’s work, so please contact <[email protected]> for permission before asking us for text files. mSupply support also distributes mSupply software for inventory control, which has an inbuilt system for reporting on medicine usage using the ATC system You can download a full working version from www.msupply.org.nz Craig Drown, mSupply Support <[email protected]> April 2000 A (2-benzhydryloxyethyl)diethyl-methylammonium iodide A03AB16 0.3 g O 2-(4-chlorphenoxy)-ethanol D01AE06 4-dimethylaminophenol V03AB27 Abciximab B01AC13 25 mg P Absorbable gelatin sponge B02BC01 Acadesine C01EB13 Acamprosate V03AA03 2 g O Acarbose A10BF01 0.3 g O Acebutolol C07AB04 0.4 g O,P Acebutolol and thiazides C07BB04 Aceclidine S01EB08 Aceclidine, combinations S01EB58 Aceclofenac M01AB16 0.2 g O Acefylline piperazine R03DA09 Acemetacin M01AB11 Acenocoumarol B01AA07 5 mg O Acepromazine N05AA04
    [Show full text]
  • Zolghadri, Samaneh, Bahrami, Asieh, Hassan Khan, Mahmud Tareq, Munoz, Jose, Garcia-Molina, Francisco, Garcia-Canovas, F
    Citation: Zolghadri, Samaneh, Bahrami, Asieh, Hassan Khan, Mahmud Tareq, Munoz, Jose, Garcia-Molina, Francisco, Garcia-Canovas, F. and Saboury, Ali Akbar (2019) A comprehensive review on tyrosinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 34 (1). pp. 279-309. ISSN 1475-6366 Published by: Taylor & Francis URL: https://doi.org/10.1080/14756366.2018.1545767 <https://doi.org/10.1080/14756366.2018.1545767> This version was downloaded from Northumbria Research Link: http://nrl.northumbria.ac.uk/37532/ Northumbria University has developed Northumbria Research Link (NRL) to enable users to access the University’s research output. Copyright © and moral rights for items on NRL are retained by the individual author(s) and/or other copyright owners. Single copies of full items can be reproduced, displayed or performed, and given to third parties in any format or medium for personal research or study, educational, or not-for-profit purposes without prior permission or charge, provided the authors, title and full bibliographic details are given, as well as a hyperlink and/or URL to the original metadata page. The content must not be changed in any way. Full items must not be sold commercially in any format or medium without formal permission of the copyright holder. The full policy is available online: http://nrl.northumbria.ac.uk/policies.html This document may differ from the final, published version of the research and has been made available online in accordance with publisher policies. To read and/or cite from the published version of the research, please visit the publisher’s website (a subscription may be required.) Journal of Enzyme Inhibition and Medicinal Chemistry ISSN: 1475-6366 (Print) 1475-6374 (Online) Journal homepage: http://tandfonline.com/loi/ienz20 A comprehensive review on tyrosinase inhibitors Samaneh Zolghadri, Asieh Bahrami, Mahmud Tareq Hassan Khan, J.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,821,928 B2 Hemmingsen Et Al
    US008821928B2 (12) United States Patent (10) Patent No.: US 8,821,928 B2 Hemmingsen et al. (45) Date of Patent: Sep. 2, 2014 (54) CONTROLLED RELEASE 5,869,097 A 2/1999 Wong et al. PHARMACEUTICAL COMPOSITIONS FOR 6,103,261 A 8, 2000 Chasin et al. 2003.01.18641 A1 6/2003 Maloney et al. PROLONGED EFFECT 2003/O133976 A1* 7/2003 Pather et al. .................. 424/466 2004/O151772 A1 8/2004 Andersen et al. (75) Inventors: Pernille Hoyrup Hemmingsen, 2005.0053655 A1 3/2005 Yang et al. Bagsvaerd (DK); Anders Vagno 2005/O158382 A1* 7/2005 Cruz et al. .................... 424/468 2006, O1939 12 A1 8, 2006 KetSela et al. Pedersen, Virum (DK); Daniel 2007/OOO3617 A1 1/2007 Fischer et al. Bar-Shalom, Kokkedal (DK) 2007,0004797 A1 1/2007 Weyers et al. (73) Assignee: Egalet Ltd., London (GB) 2007. O190142 A1 8, 2007 Breitenbach et al. (Continued) (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 FOREIGN PATENT DOCUMENTS U.S.C. 154(b) by 1052 days. DE 202006O14131 1, 2007 EP O435,726 8, 1991 (21) Appl. No.: 12/602.953 (Continued) (22) PCT Filed: Jun. 4, 2008 OTHER PUBLICATIONS (86). PCT No.: PCT/EP2008/056910 Krogel etal (Pharmaceutical Research, vol. 15, 1998, pp. 474-481).* Notification of Transmittal of the International Search Report and the S371 (c)(1), Written Opinion of the International Searching Authority issued Jul. (2), (4) Date: Jun. 7, 2010 8, 2008 in International Application No. PCT/DK2008/000016. International Preliminary Reporton Patentability issued Jul.
    [Show full text]
  • 1 Revealing SARS-Cov-2 Functional Druggability Through Multi-Target
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 11 May 2020 doi:10.20944/preprints202005.0199.v1 Revealing SARS-CoV-2 Functional Druggability Through Multi-Target Cadd Screening of Repurposable Drugs Yash Gupta1,2, Dawid Maciorowski1,3, Raman Mathur1, Catherine M Pearce1, David J. IIc1,3, Hamza Husein1,3, Ajay Bharti4, Daniel P. Becker3, Brijesh Rathi2,5, Steven B Bradfute6, Ravi Durvasula1,2, Prakasha Kempaiah1,2* 1 Loyola University Chicago Stritch School of Medicine, Chicago, IL, 60153, USA; 2 Department of Medicine, Loyola University Medical Center, Chicago, IL, 60153, USA; 3 Loyola University Chicago, Chicago, IL, USA; 4 Division of Infectious Diseases, Department of Medicine, University of California, San Diego, CA, 92093, USA, 5 Laboratory for Translational Chemistry and Drug Discovery, Hansraj College, University of Delhi, India; 6 Center for Global Health, Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA. Number of Tables: 10; Number of Figures: 16 ABSTRACT: The emergence of SARS/MERS drug resistant COVID-19 with high transmission and mortality has recently been declared a deadly pandemic causing economic chaos and significant health problems. Like all coronaviruses, SARS-CoV-2 is a large virus that has many druggable components within its proteome. In this study, we focused on repurposing approved and investigational drugs by identifying potential drugs that are predicted to effectively inhibit critical enzymes within SARS-CoV-2. We shortlisted seven target proteins with enzymatic activities known to be essential at different stages of the virus life cycle. For virtual screening, the energy minimization of a crystal structure or modeled protein was carried out using Protein Preparation Wizard (Schrödinger LLC, 2020-1).
    [Show full text]
  • WO 2017/117099 Al 6 July 2017 (06.07.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/117099 Al 6 July 2017 (06.07.2017) P O P C T (51) International Patent Classification: (US). GENESKY, Geoffery [FR/FR]; 14 Rue Royale, Λ 61Κ 8/04 (2006.01) A61K 8/97 (201 7.01) 75008 Paris (FR). A61K 8/06 (2006.01) A61K 31/70 (2006.01) (74) Agent: BALLS, R., James; Polsinelli PC, 1401 Eye A61K 8/34 (2006.01) A61K 31/351 (2006.01) Street, N.W., Suite 800, Washington, DC 20005 (US). A61K 8/60 (2006.01) A61K 31/355 (2006.01) A61K 5/67 (2006.01) A61K 31/7048 (2006.01) (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (21) International Application Number: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, PCT/US20 16/068662 BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, (22) International Filing Date: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, 27 December 2016 (27. 12.2016) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, (25) Filing Language: English MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, (26) Publication Language: English NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, (30) Priority Data: TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, 62/272,326 29 December 201 5 (29.
    [Show full text]